NIKE, Inc. · Consumer Cyclical
The price already needs more growth than analysts forecast, at both a 9% and an 8% discount rate.
At a 7.5% margin the price needs 4.2% a year of revenue growth against a -1.9% 3-year consensus: cushion -7.3pt (-4.1pt at 1pt lower r), so it is short of consensus before any correction cut. Price pays the guided FY27-28 decline and declines both recovery and disaster cases.
Would recover if: Margin proves sustainably above 7.5% or 3y consensus rises toward 4.2%; or a lower discount rate than CAPM is justified. Watch: FQ2 earnings, est. ~2026-12-18 (date not in input).. We re-check this against analyst estimates every evening.
10 years, at a 8% margin (analysts' margin, cut for cash conversion)
−0.2%/yr over 10 years once faded to terminal growth
points off 3-year analyst growth
39 published targets
Linked to AMZN, GOOGL
Does the profit analysts build their margin on actually arrive as cash? Measured over the last 3 annual statements filed before this test. After stock-based pay, 98% of reported profit arrived as operating cash, so the test cuts the analysts' 7% margin to 7%. That leaves a cushion of −10pt instead of −10pt, and the smaller of the two decides the group.
How much of reported profit arrived as operating cash. Below 0.8× is a red flag.
Profit not backed by cash, as a share of assets, latest year. Above 10% is a red flag.
Staff paid in shares instead of cash, which flatters margins. Above 10% is a red flag.
Dilution of each share's claim on the business. Above 3% a year is a red flag.
Non-operating gains in the latest year. Above 25% is a red flag.
After capex. Shown for context: heavy investment is not bad earnings, so it is never solved under.
From the priced-in reconstruction of Nov 21, 2026. Its figures use that day's price and free-cash-flow margin, so they can differ from the stress test above.
The price sits at the 31st percentile of 39 published models ($19-$68, median $37), about 11% below the median, meaning the price already pays for the guided FY2027-FY2028 decline while refusing both the $38-$68 recovery targets and the $19-$28 disaster cases; what is left unpriced is mostly the credibility of Nike's own fiscal-2031 recovery arithmetic, not the decline itself.
Does the franchise and China revenue decline actually decelerate in the coming quarters, as management's fiscal-2029 and fiscal-2031 targets require, or does the -$6bn franchise slide plus 26% China erosion keep compounding? Unit_volumes via segment_revenue_history can settle the franchise/China revenue part directly, and consumer_attention can give early warning on the four big franchises — so the core decline is testable, but the pricing and product-mix assumptions behind the fiscal-2031 margin target are not wired.
A stress test of whether this narrative is still paid for by analyst forecasts, not a forecast that the stock will rise. The price-implied growth on its own has not predicted returns in our testing, and this list (sealed Nov 21, 2026) has not been graded yet. Cut sizes are assumptions. Not investment advice. Back to all names